True Wealth Design, LLC Travere Therapeutics, Inc. Transaction History
True Wealth Design, LLC
- $258 Billion
- Q4 2024
A detailed history of True Wealth Design, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 288 shares of TVTX stock, worth $6,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
288
Previous 228
26.32%
Holding current value
$6,010
Previous $3.19 Million
57.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$160 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$154 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$141 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$104 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$88.9 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.34B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...